Upload
trinhphuc
View
222
Download
0
Embed Size (px)
Citation preview
366
fever from Central America. Our Ministry of Healthwould be doing a useful service if it prepared a similardocument, oriented to our domestic needs, and issued itwith the Prescriber’s Journal.
TREATMENT OF BACILLARY DYSENTERY
EVEN in Great Britain, where the more severe forms ofthe disease are uncommon, acute bacillary dysenterydeserves active treatment. Sulphonamides and someantibiotics will quickly relieve the distressing symptoms,will save some lives among the very young and very old,and will shorten the period during which the patient isa source of infection to others. The quicker the treatmentis begun the better; but the choice of the drug, among somany which are effective, is not always easy. One of ourmost valuable allies in the late war was sulphaguanidine,which not only saved many lives but won battles. This
drug has now given way to more active compounds of thesame class; and, without much justification, there has beena tendency to revert to those which are absorbed moreeasily. Streptomycin by mouth is at least as efficacious asthese, and in combination with one or more of the sul-phonamides has become a household remedy for diarrhoeain some parts of the tropics. Later studies have suggestedthat some of the broad-spectrum antibiotics are even moreeffective. Bibile et al.1 in Ceylon confirm that tetracyclinedispels the patient’s symptoms and frees him from infec-tion more quickly than do sulphadimidine, sulpha-methoxypyridiazine, or ’ Streptotriad ’ (a combination ofsulphadiazine, sulphamerazine, sulphathiazole, and strep-tomycin) but that between these last three there is nothingto choose. Tetracycline is not cheap, and these workerssuggest that a long-acting sulphonamide should be usedfirst and that, if clinical cure does not follow almost atonce, tetracycline should be used instead.
In time, no doubt, the ingenious pharmacologists willfabricate even more effective remedies for bacillarydysentery; but published reports show that it is becomingmore and more difficult to prove that one treatment isbetter than another. Some patients with this disease arecured very quickly by non-specific treatment or with notreatment at all. It is no longer easy to collect enoughcomparable cases. In this country the admission to hos-
pital of any but the most severely ill is discouraged-andrightly so-and where the disease is endemic and abundant,hospitals, laboratories, and doctors are scarce. Ceylon isan exception, but there are reasons for hoping that there,too, it will soon be difficult to find enough patients withthis disease. When four methods of treatment, each
applied to a group of 20 patients, are to be compared, thedifferences in the results must be considerable if they areto convince even the most credulous statistician. Future
comparisons will be between drugs all of which givesatisfactory results in nine patients out of ten. Those whomake these comparisons should come to some agreementon the criteria of success: here W.H.O. might help. Tothe doctor at the beside the duration of fever and/or ofdiarrhoea is the most valuable test of cure: to the hygienistit is the absence of the causal organism from the faeces.The latter is the easier to measure precisely, but its
importance may be overvalued: experience supportsRoss’s suggestion that at any rate in Sonne dysentery thesymptomless excretor seldom spreads infection.2 Occasion-ally children who have recovered from Sonne dysentery1. Bibile, S. W., Balasubramaniam, K., Cooray, M. P. M., Gulasekaram, J.
J. trop. Med. Hyg. 1961, 64, 300.2. Ross, A. I. Mon. Bull. Minist. Hlth Lab. Serv. 1955, 14, 16.
continue to excrete the organism for weeks or even monthsdespite intensive treatment with drugs. This feature, inwhich drug resistance seems to play no part, seems to bebecoming commoner, and it suggests the establishment ofa symbiotic relationship which will complicate the inter-pretation of the tests of bacterial cure. As far as we know,such long-continued carriage of the causal organism israre after infection with the other shigellas, and there areother reasons for doubting whether all the facts derivedfrom one can be applied to the others. Sonne dysenteryis usually but not always milder than infections due toSh. flexneri or shigz. At any rate, in Great Britain, thedisease has a natural history all of its own. Like otherintestinal infections it used to flourish in the summer andautumn, but in the past ten years it has become a diseaseof the winter and spring. The organism is surprisinglyresistant to an unfriendly environment. It can be spreadby food and drink, but other routes play a major part inits spread. As a nation we have been martyrs to thisinfection since the war, but no country has a better supplyof potable water. Where Sonne and Flexner dysenteryoccur together (as in Cyprus) no obvious differencebetween them can be detected, but this does not mean thatSonne dysentery in Aberdeen will always behave likeFlexner dysentery in Colombo. Bibile’s paper relates toFlexner dysentery only, and is the more valuable for thisreason.
Those who describe therapeutic trials do not always tellus enough about the relative costs : generally speaking, weprefer the cheapest. Bibile’s recommendation of a long-acting sulphonamide with tetracycline as a standby seemsrational. Tests of cure involve matters of conscience aswell as of fact. As a rule the patient who is fit to leave hisbed is fit to leave the hospital, but we should have moreexact knowledge of the part played by the convalescent inspreading infection. Few except the bacteriologists worrymuch about the flora of their own bowels.
AEROSOLS AND PNEUMONIA
THE inhalation of aerosols containing spasmolytic drugsfor the relief of bronchospasm has become establishedpractice. Attempts to thin tenacious bronchial secretionswith proteolytic enzymes similarly given have not so farproved entirely satisfactory; c.nd in respiratory infectionsantibiotics are now seldom given in this way. Grant’ 1
concluded that this method " has not proved a satisfactorytechnique for the administration of antibiotics even wheninfection is apparently localised to the bronchial mucosa ".A recent report from the United States 2 describes an
attempt to combine an aerosol proteolytic enzyme, pan-creatic dornase, with an aerosol antibiotic. These twosubstances were given via an intermittent positive-pressurerespirator to 30 patients with pneumonias of various
types who were already receiving systemic antibiotics.15, mostly elderly men, had staphylococcal pneumonia,and in 6 cases this had followed operation. Paine et a1.2found that aerosols used in this way were a useful adjunctand helped appreciably in thinning tenacious infectedsputum. No patient died in this series and the techniquewas of particular benefit to old and weak patients. Paineet al. conclude that "in a patient seriously ill with
pneumonia, the combined use of systemic antibiotics withaerosols of pancreatic dornase and antibiotics is probablythe most effective method
"
1. Grant, I. W. B. Practitioner, 1958, 181, 703.2. Paine, J. R., Spier, R., Witebsky, E. J. Amer. med. Ass. 1961, 178, 878.